A new procedure was elaborated by the medical researchers who claim that this procedure may rationally predict which men receiving prostate cancer treatment will develop ED as a result.
In the future the procedure could influence the decision for males choosing whether to undergo particular prostate cancer treatment or not, anticipating if the tumor remains stable or starts growing actively.
The main goal in treating any cancer is to prolong life and make certain that a sufferer will survive. The study senior author Dr. Martin G. Sanda, director of the prostate center at Beth Israel Deaconess Medical Center in Boston is sure that with an early-stage prostate cancer properly diagnosed most men survive. The query arisen in such situation is to elaborate better methods predicting the kind of adverse effects each patient can possibly suffer from the treatment.

The approach offered by the researches is based on an evaluation of existing before treatment sexual function, way of life, and clinical markers. So it could offer necessary clearness for newly diagnosed males.
The tests such as the prostate-specific antigen (PSA) blood test and other specific procedures suggest if a prostate tumor exists. The reason to use such approach is that most of these tumors are slow-growing and cause little threat to a general health of a man. Still doctors consider that it’s hard to identify if the tumors are active and aggressive or not the resolution to undergo active treatment overweighs.
Most cancer treatments have severe side effects, and prostate cancer therapy often causes erectile dysfunction (ED), bowel dysfunction. The researchers pointed out erectile dysfunction problem as loss of sexual function in previously sexually active males is the most common adverse effect they observe. This side effect has a great negative impact on man’s life making men worry about the treatment outcome.
The study involved more than 1,200 newly diagnosed men with prostate cancer.
The surveys, conducted during a long period of time, included patient age, prostate cancer severity, PSA levels, body mass index, race and ethnicity, current sexual function, and prior history of ED or ED treatment.
Eventually, all the participants had to undergo prostate cancer therapy, and all were observed for two years after the treatment.
According to the finding of the study a man’s risk of impotence varied resting on the type of treatment provided. Males without ED issues before treatment, after having surgical removal of the prostate developed ED in about 60 % of cases within 2 years of therapy. About 40 %of men without ED had the problem with erections following external radiation, and fewer than 40 % of cases for those who underwent brachytherapy.
The study also revealed that such characteristic as high PSA levels, were related to higher ED development risk.
The approach includes many other factors which can influence on the development of ED. The researchers confirm that the method they used “can really help people weigh the potential benefits of reducing the risk of dying from prostate cancer versus the price they might have to pay”.

Related posts:

  1. Can Men Over 70 Be Sexually Active?

Comments are closed.

Related Posts (YARPP)